Mycophenolate Mofetil
Who holds supplier records for Mycophenolate Mofetil? 19 organisations hold a current record for Mycophenolate Mofetil: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 12 of them hold a valid EU Certificate of Suitability (13 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (8), China (3), Slovenia (1), Taiwan (1) and 2 other countries (2); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Mycophenolate Mofetil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mycophenolate-mofetil
Reading the evidence
- 19 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Mycophenolate Mofetil expires 16 Aug 2039. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (19)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Mycophenolate Mofetil. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CONCORD BIOTECH LTDIndiaCEP Company GMP cert on recordActive DMF 19231, 29553 · latest filing Sept 2015
- CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDCompany GMP cert on recordActive DMF 33333, 18494 · latest filing Dec 2018
- Biocon LimitedIndiaCEPActive DMF 16406 · latest filing Jan 2003
- Chongqing Daxin Pharmaceutical Co., Ltd.ChinaCEPActive DMF 20758, 36449 · latest filing Dec 2021
- Emcure Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 25744 · latest filing Feb 2012
- HISUN PHARMACEUTICAL HANGZHOU CO LTDCEPActive DMF 26405 · latest filing Nov 2012
- Lek Pharmaceuticals D.D.SloveniaCEP Company GMP cert on recordActive DMF 25323, 18936 · latest filing Sept 2011
- RAKSHIT PHARMACEUTICALS LTDCEPActive DMF 42257 · latest filing Aug 2025
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 33021 · latest filing Jul 2018
- Wuxi Fortune Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 22786, 33934 · latest filing Aug 2019
- DASAMI LAB PRIVATE LTDIndia Company GMP cert on recordActive DMF 42682 · latest filing Nov 2025
- Formosa Laboratories, Inc.Taiwan Company GMP cert on recordActive DMF 22046 · latest filing Oct 2008
- Intas Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 43405 · latest filing Feb 2026
- JOYANG LABORATORIESChinaActive DMF 40978 · latest filing Oct 2025
- Shandong New Time Pharmaceutical Co LtdCompany GMP cert on recordActive DMF 20655 · latest filing Jul 2007
- TAPI NL BVNetherlandsActive DMF 20072 · latest filing Dec 2006
- Apotex Pharmachem India Pvt. Ltd.IndiaCEPInactive DMF 25746, 21227 · latest filing Jan 2012
- Rpg Life Sciences Ltd.IndiaCEP Company GMP cert on recordInactive DMF 26578 · latest filing Jan 2013
- TAPI Czech Industries s.r.oCzech RepublicCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (13)
Certificates of Suitability on the EDQM register for Mycophenolate Mofetil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI CZECH INDUSTRIES S.R.O. Opava | CZ | CEP 2005-239 - Rev 07 Mycophenolate mofetil | May 2026 | Inspected Oct 2024 Czechia |
| EMCURE PHARMACEUTICALS LIMITED Pune | IN | CEP 2019-089 - Rev 03 Mycophenolate mofetil | Mar 2026 | — |
| RPG LIFE SCIENCES LIMITED Navi Mumbai | IN | CEP 2025-548 - Rev 00 Mycophenolate mofetil, Process II | Feb 2026 | — |
| WUXI FORTUNE PHARMACEUTICAL CO., LTD. Wuxi | CN | CEP 2019-159 - Rev 01 Mycophenolate mofetil, Process 2 | Nov 2024 | Inspected Mar 2025 Germany |
| BIOCON LIMITED Bengaluru | IN | CEP 2010-162 - Rev 09 Mycophenolate mofetil, Process II | Nov 2024 | — |
| LEK PHARMACEUTICALS D.D. Ljubljana | SI | CEP 2011-317 - Rev 06 Mycophenolate mofetil, Process B | Sept 2024 | Inspected Nov 2025 Slovenia |
| RAKSHIT PHARMACEUTICALS LIMITED Vishakhapatnam | IN | CEP 2022-182 - Rev 00 Mycophenolate mofetil | May 2024 | — |
| CONCORD BIOTECH LIMITED Ahmedabad | IN | CEP 2009-361 - Rev 06 Mycophenolate mofetil | Mar 2024 | — |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | CEP 2019-344 - Rev 01 Mycophenolate mofetil | Jan 2024 | — |
| CHONGQING DAXIN PHARMACEUTICAL CO., LTD. Shuitu Town | CN | R0-CEP 2020-104 - Rev 00 Mycophenolate mofetil | Mar 2022 | — |
| HISUN PHARMACEUTICAL (HANGZHOU) CO., LTD. Hangzhou City | CN | R1-CEP 2012-308 - Rev 02 Mycophenolate mofetil | Oct 2021 | — |
| APOTEX PHARMACHEM INDIA PVT. LTD Bangalore | IN | R1-CEP 2013-263 - Rev 00 Mycophenolate mofetil, MYM | Feb 2019 | — |
| BIOCON LIMITED Bangalore | IN | R1-CEP 2007-052 - Rev 00 Mycophenolate mofetil | Jul 2013 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Mycophenolate Mofetil are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- China · Inactive DMF 25336 · filed Sept 2011
- South · Inactive DMF 24981 · filed May 2011
- HAUDONG MEDICINE CO LTDInactive DMF 22977 · filed Jul 2009
- SHANGHAI YOUNGGREEN BIOTECH CO LTDInactive DMF 21423 · filed Mar 2008
- DSM ANTI INFECTIVES BVInactive DMF 21232 · filed Jan 2008
- India · Inactive DMF 20679 · filed Nov 2007
- Germany · Inactive DMF 20948 · filed Oct 2007
- IVAX PHARMACEUTICALS SROInactive DMF 18989 · filed Nov 2005
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (38 listed products contain Mycophenolate Mofetil). The latest listed patent expires 16 Aug 2039. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Mycophenolate mofetil is an immunosuppressive agent used to prevent organ transplant rejection. It acts by inhibiting the proliferation of activated T and B lymphocytes.
Chemical identity
- IUPAC name
- 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
- Canonical SMILES
- CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O
- InChIKey
- RTGDFNSFWBGLEC-SYZQJQIISA-N
- Synonyms
- CellCept API, myclausen, mycophenolate mofetil teva, mycophenylate mofetil, myfenax, myhibbin, nsc-724229, nsc-758905, rs-61443
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Antimetabolite Immunosuppressant
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Mycophenolate Mofetil?
19 organisations hold an active US FDA Type II Drug Master File or a CEP for Mycophenolate Mofetil: CONCORD BIOTECH LTD (India), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD, Biocon Limited (India), Chongqing Daxin Pharmaceutical Co., Ltd. (China), Emcure Pharmaceuticals Limited (India), HISUN PHARMACEUTICAL HANGZHOU CO LTD, Lek Pharmaceuticals D.D. (Slovenia) and RAKSHIT PHARMACEUTICALS LTD, and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Mycophenolate Mofetil Drug Master Files are active?
CONCORD BIOTECH LTD (DMF 19231, 29553), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD (DMF 33333, 18494), Biocon Limited (DMF 16406), Chongqing Daxin Pharmaceutical Co., Ltd. (DMF 20758, 36449), Emcure Pharmaceuticals Limited (DMF 25744), HISUN PHARMACEUTICAL HANGZHOU CO LTD (DMF 26405), Lek Pharmaceuticals D.D. (DMF 25323, 18936) and RAKSHIT PHARMACEUTICALS LTD (DMF 42257) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Mycophenolate Mofetil records mean?
8 organisations have only inactive Type II DMFs for Mycophenolate Mofetil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Mycophenolate Mofetil have a European Certificate of Suitability?
Yes. 12 organisations hold a valid CEP for Mycophenolate Mofetil on the EDQM register, including TAPI CZECH INDUSTRIES S.R.O. Opava (CZ), EMCURE PHARMACEUTICALS LIMITED Pune (IN), RPG LIFE SCIENCES LIMITED Navi Mumbai (IN), WUXI FORTUNE PHARMACEUTICAL CO., LTD. Wuxi (CN), BIOCON LIMITED Bengaluru (IN) and LEK PHARMACEUTICALS D.D. Ljubljana (SI) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Mycophenolate Mofetil?
Yes. The latest patent listed for an approved US product containing Mycophenolate Mofetil expires 16 Aug 2039, across 38 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Mycophenolate Mofetil supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Mycophenolate Mofetil?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.